| Home Market Dynamics Sector Analysis Company Insights AI Investing Strategies Contact Us Login |
| Johnson & Johnson is making significant strides in Product/Service Development, particularly with innovative treatments for ulcerative colitis, underlined by positive Phase 3 trial results highlighting efficacy for pediatric patients. Additionally, advancements in contact lens technology and expansion in MedTech sales reflect strong product development capabilities and competitive positioning in various healthcare sectors. The ongoing development potential of emerging therapeutics further emphasizes J&J's commitment to enhancing their product portfolio. However, challenges may arise from market competition and regulatory hurdles that could impact timely product launches. |
| The price action of JOHNSON & JOHNSON (JNJ) is impacted by broad market risk appetite, sector price trend, company-specific performance and market structure. The market sentiment at -0.1 is modestly bearish. Trend sentiment measures the current trend of the stock price, and market sentiment reflects what market participants collectively think where the price will move next.There is no clear direction for JNJ since trend sentiment and market sentiment are at the opposite directions. The positive sentiment force for sector is at 0.1, and the negative at -0.2 on 2025-10-13. The forces of and Valuation Sentiment (-1) will drive down the price. The forces of Stock Price Trend (0), Sector Price Trend (0), Price Level Sentiment (0), Option Sentiment (0), Market Risk Appetite (0), and Sentiment towards Fundamentals (0.6) will drive up the price. The sentiment for Sector Price Trend is calculated based on the price trend of related sector ETF. The sentiment for Option Speculation is calculated from put/call ratio. The Risk Appetite is calculated from Bitcoin price trend. Price Level sentiment is positive when oversold, and negative when overbought. Valuation Sentiment, and Sentimentals towards Fundamentals are extracted from headlines and market commentary. All sentiment scores are normalized on a -10 - +10 scale. The price level reaches 100 at Bollinger upper band, and zero at lower band. |
| JNJ | |||||||||||||
| Date | Attention | Price | Price Level | Change | SMA10 Trend | Trend Sentiment | Hourly Trend | Hourly StdDev | Market Sentiment | Action | P | Fund. | News Sentiment |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-10-13 | 0%(0%) | 0 | 0% | -0.1 | 0.6 | -1 | |||||||
| 2025-10-12 | 0%(0%) | 0 | 0% | -0.1 | 0.7 | -1 | |||||||
| 2025-10-11 | 0%(0%) | 0 | 0% | -0.1 | 0.2 | -1 | |||||||
| 2025-10-10 | 0%(0%) | 0 | 0% | -0 | 0.9 | 5 | |||||||
| 2025-10-09 | 0%(0%) | 0 | 0% | 0.1 | 1.3 | -1 | |||||||
| 2025-10-08 | 0%(0%) | 0 | 0% | 0 | 1.2 | 7 | |||||||
| 2025-10-07 | 0%(0%) | 0 | 0% | 0 | 1.2 | -9 | |||||||
| 2025-10-06 | 0%(0%) | 0 | 0% | 0.4 | 3.5 | -1 | |||||||
| 2025-10-05 | 0%(0%) | 0 | 0% | 0.5 | 4.2 | -1 | |||||||
| 2025-10-04 | 0%(0%) | 0 | 0% | 0.5 | 4.2 | -1 | |||||||
| Wait action is recommended in three scenarios with either high uncertainty or high risk: 1. The trend sentiment and market sentiment are at the opposite directions. 2. Both trend sentiment and market sentiment are positive, but the price level is elevated. 3. Both trend sentiment and market sentiment are negative, but the price level is depressed. In an uptrend, as an investor, you may want to wait for the pullback to open long position. In a downtrend, the price will likely rebound after huge decline. As an investor, you may want to wait for the rebound to exit long position. | |||||||||||||
| Market sentiment will accelerate the current trend when both trend sentiment and market sentiment are at the same direction. Market sentiment will generate volatility when it's at the opposite direction of the trend sentiment. News sentiment measures the daily emotion of the market. News sentiment may impact the daily price change while market sentiment is a more stable and consistent moving force. | |||||||||||||
| 2025-10-13 17:03:01 Analysts are optimistic about J&J's upcoming financial results, reflecting positive expectations for the company's performance. |
| 2025-10-13 17:03:01 Despite growing sales, challenges such as China's VBP program pose risks to J&J's MedTech growth. |
| 2025-10-13 17:03:01 The stability of J&J's stock near all-time highs suggests investor confidence and strong market performance. |
| 2025-10-13 17:03:01 J&J's MedTech segment is showing growth, particularly in cardiovascular, surgery, and vision sectors, indicating successful product development. |
| 2025-10-13 17:03:01 The positive performance of Johnson & Johnson's stock is linked to strong earnings and the expectation of beating analyst estimates. |